Vnitr Lek 2007, 53(7-8):853-858

Oral treatment of type 2 diabetes mellitus

J. Olšovský
Diabetologické centrum II. interní kliniky Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Miroslav Souček, CSc.

The article informs about current views of the ethiopathogenesis of type 2 diabetes mellitus (DM). It presents diabetes as a disease which is chronic and progressive, therefore requiring a dynamic approach to treatment. Based on the above concept, the article lists the current armamentarium of oral antidiabetic drugs and the possibilities of their combining. In addition to the existing therapeutic options, it also brings information about innovative drugs from the above group to be made available in the near future.

Keywords: type 2 diabetes mellitus

Received: June 4, 2007; Published: July 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Olšovský J. Oral treatment of type 2 diabetes mellitus. Vnitr Lek. 2007;53(7-8):853-858.
Download citation

References

  1. Butier AE, Janson J, Boner-WeirS et al. Mechanism of reduction of betacell. Diabetes 2003; 52: 102-110. Go to original source... Go to PubMed...
  2. Kahn SE, Hafner SM, Hense MA et al. Glycemic durability of rosiglitazone, metformin or gluburide monotherapy. N Engl J Med 2006; 355: 2427-2443. Go to original source... Go to PubMed...
  3. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in Type 2 diabetes, a consensus algorithm for the initiation and adjustment of therapy. Diabetologia 2006; 49: 1711-1721. Go to original source... Go to PubMed...
  4. Olšovský J. Možnosti ovlivnění inzulinové rezistence. Farmakoterapie 2007; 1: 29-33.
  5. Perušičová J et al. Perorální antidiabetika. 1. ed. Praha: Galén 2003.
  6. Williams G, Pickup JC (eds). Handbook of Diabetes. 3rd ed. Oxford: Blackwell 2003.
  7. www.diab.cz: Standardy: Laboratorní diagnostika a sledování stavu DM.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.